164 related articles for article (PubMed ID: 25755696)
1. FOXA1 positively regulates gene expression by changing gene methylation status in human breast cancer MCF-7 cells.
Zheng L; Qian B; Tian D; Tang T; Wan S; Wang L; Zhu L; Geng X
Int J Clin Exp Pathol; 2015; 8(1):96-106. PubMed ID: 25755696
[TBL] [Abstract][Full Text] [Related]
2. miR-204 regulates the biological behavior of breast cancer MCF-7 cells by directly targeting FOXA1.
Shen SQ; Huang LS; Xiao XL; Zhu XF; Xiong DD; Cao XM; Wei KL; Chen G; Feng ZB
Oncol Rep; 2017 Jul; 38(1):368-376. PubMed ID: 28534958
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of the HSP72 by Foxa1 in MCF-7 human breast cancer cell line.
Song L; Xu Z; Zhang C; Qiao X; Huang C
Biochem Biophys Res Commun; 2009 Aug; 386(1):30-4. PubMed ID: 19486887
[TBL] [Abstract][Full Text] [Related]
4. [Interaction between miR-21 and DNA methylation in different breast cancer cells].
Zhang YY; Tian WP; Mei M
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 May; 31(3):220-4. PubMed ID: 26387181
[TBL] [Abstract][Full Text] [Related]
5. FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer.
Gong C; Fujino K; Monteiro LJ; Gomes AR; Drost R; Davidson-Smith H; Takeda S; Khoo US; Jonkers J; Sproul D; Lam EW
Oncogene; 2015 Sep; 34(39):5012-24. PubMed ID: 25531315
[TBL] [Abstract][Full Text] [Related]
6. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
8. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
[TBL] [Abstract][Full Text] [Related]
9. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
10. Analyses of an epigenetic switch involved in the activation of pioneer factor FOXA1 leading to the prognostic value of estrogen receptor and FOXA1 co-expression in breast cancer.
Jing X; Liang H; Hao C; Hongxia L; Cui X
Aging (Albany NY); 2019 Sep; 11(18):7442-7456. PubMed ID: 31562808
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide profiling in melatonin-exposed human breast cancer cell lines identifies differentially methylated genes involved in the anticancer effect of melatonin.
Lee SE; Kim SJ; Yoon HJ; Yu SY; Yang H; Jeong SI; Hwang SY; Park CS; Park YS
J Pineal Res; 2013 Jan; 54(1):80-8. PubMed ID: 22856590
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1).
Williamson EA; Wolf I; O'Kelly J; Bose S; Tanosaki S; Koeffler HP
Oncogene; 2006 Mar; 25(9):1391-9. PubMed ID: 16331276
[TBL] [Abstract][Full Text] [Related]
13. Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation.
Leu YW; Rahmatpanah F; Shi H; Wei SH; Liu JC; Yan PS; Huang TH
Cancer Res; 2003 Oct; 63(19):6110-5. PubMed ID: 14559786
[TBL] [Abstract][Full Text] [Related]
14. FoxA1 as a lineage-specific oncogene in luminal type breast cancer.
Yamaguchi N; Ito E; Azuma S; Honma R; Yanagisawa Y; Nishikawa A; Kawamura M; Imai J; Tatsuta K; Inoue J; Semba K; Watanabe S
Biochem Biophys Res Commun; 2008 Jan; 365(4):711-7. PubMed ID: 18039470
[TBL] [Abstract][Full Text] [Related]
15. Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells.
Putnik M; Zhao C; Gustafsson JÅ; Dahlman-Wright K
Biochem Biophys Res Commun; 2012 Sep; 426(1):26-32. PubMed ID: 22902638
[TBL] [Abstract][Full Text] [Related]
16. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
17. FOXA1 hypermethylation: link between parity and ER-negative breast cancer in African American women?
Espinal AC; Buas MF; Wang D; Cheng DT; Sucheston-Campbell L; Hu Q; Yan L; Payne-Ondracek R; Cortes E; Tang L; Gong Z; Zirpoli G; Khoury T; Yao S; Omilian A; Demissie K; Bandera EV; Liu S; Ambrosone CB; Higgins MJ
Breast Cancer Res Treat; 2017 Nov; 166(2):559-568. PubMed ID: 28756535
[TBL] [Abstract][Full Text] [Related]
18. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
[TBL] [Abstract][Full Text] [Related]
19. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
[TBL] [Abstract][Full Text] [Related]
20. FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
Nucera C; Eeckhoute J; Finn S; Carroll JS; Ligon AH; Priolo C; Fadda G; Toner M; Sheils O; Attard M; Pontecorvi A; Nose V; Loda M; Brown M
Clin Cancer Res; 2009 Jun; 15(11):3680-9. PubMed ID: 19470727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]